NCT06159816View on ClinicalTrials.gov

PREVALENCE STUDY OF PNH CLONES IN PATIENTS WITH NEOPLASIES

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2022

Conditions

Myeloproliferative Neoplasm

Trial Locations (1)

48121

Ausl Della Romagna, Ravenna

All Listed Sponsors

lead

AUSL Romagna Rimini

OTHER

NCT06159816 - PREVALENCE STUDY OF PNH CLONES IN PATIENTS WITH NEOPLASIES | Biotech Hunter | Biotech Hunter